奇正藏藥(002287.SZ):擬與廣藥金申、廣藥白雲山設基金 專項投資於白雲山一心堂公司
格隆匯 3 月 8日丨奇正藏藥(002287.SZ)公佈,2021年3月7日,公司四屆董事會第三十二次會議審議通過了《關於參與設立股權投資基金的議案》,同意公司與廣東廣藥金申股權投資基金管理有限公司(“廣藥金申”)、廣州白雲山醫藥集團股份有限公司(“廣藥白雲山”)簽訂《廣州廣藥金藏股權投資合夥企業(有限合夥)合夥協議》,共同設立廣州廣藥金藏股權投資合夥企業(有限合夥)(以工商注冊為準,“合夥企業”、“基金”),總規模為1.15億元,公司作為有限合夥人認繳出資6785萬元,認繳比例為59%。以上資金均為自有資金。
基金專項投資於廣州白雲山一心堂醫藥投資發展有限公司(“白雲山一心堂公司”),用於醫藥零售企業廣東百源堂醫藥連鎖有限公司(“百源堂”)的發展。待基金募資設立、完成備案等相關程序後,除預留管理費外,將以500萬元的對價受讓廣藥金申持有的白雲山一心堂公司35%股權並實繳剩餘1億元出資。
根據《公司法》、《深圳證券交易所股票上市規則》和《公司章程》等相關規定,此次參與設立基金事項無需提交公司股東大會審議,不構成關聯交易,亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組,無需經過有關部門批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.